ARTICLE SUMMARY:
Medical device shortage tracking during emergencies and the recently established medical device expert panels will be administered by the EU’s centralized pharmaceutical regulator starting March 1 under a newly approved framework.
The EU has approved new authorities for the European Medicines Agency (EMA) to oversee medical device activities. The new framework was endorsed by the EU Parliament last week to take effect March 1. It is principally focused on emergency preparedness, but the new rules also would increase EMA’s involvement in the operations of the “expert panels” that were recently established by the Medical Device Regulation, even in non-emergency times.
